In this commentary, Raymond Chung, MD, from Massachusetts General Hospital, explains why it is key to stage a patient’s disease after an HCV diagnosis—and how to do it.
A recent survey of individuals with hepatitis C who inject drugs aimed to highlight the nonclinical impacts of HCV treatment. Have your patients in this population experienced improvements in quality of life? Let us know by taking our poll.
A recent study highlighted the barriers to therapy for patients with HIV/HCV coinfection. Have you experienced barriers to your patients receiving HCV therapy? Voice your opinion via our latest poll!
In this podcast, Jeff Jin, PhD, discusses his team's recent study, which examined the prevalence of hepatitis C virus infection among men who have sex with men.